Snehal Patel, the CEO and CFO of $GLSI ($GLSI), bought 2,400 shares of the company on 12-31-2024. This trade was reported by Quiver Quantitative using data from a ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
Greenwich LifeSciences (GLSI) stock is a "Buy" as phase 3 FLAMINGO-01 advances in HER2-positive breast cancer with two major ...
Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) shares are trading higher Monday after the company announced it extended its lock-up period to Sept. 30, 2026. What To Know: Greenwich LifeSciences said its ...
The MarketWatch News Department was not involved in the creation of this content. STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results